75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The market capitalization of the company stood at Rs. 7,000 crore +
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Sets price band at ?695 to ?735 per Equity Share
Subscribe To Our Newsletter & Stay Updated